|Bid||1.1100 x 2900|
|Ask||1.1100 x 4000|
|Day's Range||1.0400 - 1.4000|
|52 Week Range||0.2400 - 1.9400|
|Beta (5Y Monthly)||3.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 24, 2021 - Mar 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.63|
NovaBay announces Avenova and CelleRx Clinical Reset to be available in brick-and-mortar stores.
NovaBay Pharmaceuticals announces its proprietary hypochlorous acid solution has received EPA approval for SARS-CoV-2 kill claim.
NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement